EGFR and neoplasm: Aiming to fill up the gap, we demonstrated that high tumor mutation load might mediate tumor progression and recurrence by activating the immune escape mechanism and that high mutation load in the EGFR wild‐type patients correlated with worse relapse‐free survival.